Advertisement

Malaria

  • Joseph B. Cantey
Chapter

Abstract

Malaria accounts for a substantial amount of perinatal morbidity and mortality among infants born to women living in or traveling to malaria-endemic areas. Infants with congenital or postnatally acquired malaria present with fever, hemolytic anemia, and splenomegaly. Diagnosis can be made by examining thick and thin blood smears. Prompt treatment with oral therapy is associated with good outcomes in most cases, but severe disease may require intravenous therapy or even exchange transfusion to reduce parasite load. Prevention efforts should focus on mosquito avoidance and antimalarial prophylaxis.

Keywords

Congenital malaria Mosquito Parasite Blood smear 

References

  1. 1.
    Conroy AL, McDonald CR, Kain KC. Malaria in pregnancy: diagnosing infection and identifying fetal risk. Expert Rev Anti-Infect Ther. 2012;10:1331–42.CrossRefPubMedGoogle Scholar
  2. 2.
    Moore KA, Simpson JA, Scoullar MJL, et al. Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1101–12.CrossRefPubMedGoogle Scholar
  3. 3.
    Mace KE, Arguin PM. Malaria surveillance—United States, 2014. MMWR Surveill Summ. 2017;66:1–24.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cullen KA, Mace KE, Arguin PM. Malaria surveillance—United States, 2013. MMWR Surveill Summ. 2016;65:1–22.CrossRefPubMedGoogle Scholar
  5. 5.
    Cullen KA, Arguin PM. Malaria surveillance—United States, 2012. MMWR Surveill Summ. 2014;63:1–22.PubMedGoogle Scholar
  6. 6.
    Cullen KA, Arguin PM. Malaria surveillance—United States, 2011. MMWR Surveill Summ. 2013;62:1–17.PubMedGoogle Scholar
  7. 7.
    Mali S, Kachur SP, Arguin PM. Malaria surveillance—United States, 2010. MMWR Surveill Summ. 2012;61:1–17.PubMedGoogle Scholar
  8. 8.
    Mali S, Tan KR, Arguin PM. Malaria surveillance—United States, 2009. MMWR Surveill Summ. 2011;60:1–15.PubMedGoogle Scholar
  9. 9.
    Mali S, Steele S, Slutsker L, Arguin PM. Malaria surveillance—United States, 2008. MMWR Surveill Summ. 2010;59:1–15.PubMedGoogle Scholar
  10. 10.
    Mali S, Steele S, Slutsker L, Arguin PM. Malaria surveillance—United States, 2006. MMWR Surveill Summ. 2008;57:24–39.PubMedGoogle Scholar
  11. 11.
    Thwing J, Skarbinski J, Newman RD, et al. Malaria surveillance—United States, 2005. MMWR Surveill Summ. 2007;56:23–40.PubMedGoogle Scholar
  12. 12.
    Teo A, Feng G, Brown GV, et al. Functional antibodies and protection against blood-stage malaria. Trends Parasitol. 2016;32:887–98.CrossRefPubMedGoogle Scholar
  13. 13.
    Agomo CO, Oyibo WA. Factors associated with risk of malaria infection among pregnant women in Lagos, Nigeria. Infect Dis Poverty. 2013;2:19.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Beeson JG, Rogerson SJ, Elliott SR, Duffy MF. Targets of protective antibodies to malaria during pregnancy. J Infect Dis. 2005;192:1647–50.CrossRefPubMedGoogle Scholar
  15. 15.
    Okafor UH, Oguonu T, Onah HE. Risk factors associated with congenital malaria in Enugu, South Eastern Nigeria. J Obstet Gynaecol. 2006;26:612–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167:610–24.CrossRefPubMedGoogle Scholar
  17. 17.
    Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placenta—the role of malaria. Placenta. 2004;25:359–78.CrossRefPubMedGoogle Scholar
  18. 18.
    Eisele TP, Larsen DA, Anglewicz PA, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12:942–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Menendez C, Ordi J, Ismail MR, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis. 2000;181(5):1740.CrossRefPubMedGoogle Scholar
  20. 20.
    Hershey CL, Florey LS, Ali D, et al. Malaria control interventions contributed to declines in malaria parasitemia, severe anemia, and all-cause mortality in children less than 5 years of age in Malawi, 2000-2010. Am J Trop Med Hyg. 2017;97:76–88.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ramharter M, Schuster K, Bouyou-Akotet MK, et al. Malaria in pregnancy before and after the implantation of a national IPTp program in Gabon. Am J Trop Med Hyg. 2007;77:418–22.PubMedCrossRefGoogle Scholar
  22. 22.
    Vottier G, Arsac M, Farnoux C, et al. Congenital malaria in neonates: two case reports and review of the literature. Acta Paediatr. 2008;97:505–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Lesko CR, Arguin PM, Newman RD. Congenital malaria in the United States: a review of cases from 1966 to 2005. Arch Pediatr Adolesc Med. 2007;161:1062–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Opare DA. Congenital malaria in newborn twins. Ghana Med J. 2010;44:76–8.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Hagmann S, Khanna K, Niazi M, Purswani M, Robins EB. Congenital malaria, an important differential diagnosis to consider when evaluating febrile infants of immigrant mothers. Pediatr Emerg Care. 2007;23:326–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Boudova S, Divala T, Mungwira R, et al. Placental but not peripheral Plasmodium falciparum infection during pregnancy is associated with increased risk of malaria in infancy. J Infect Dis. 2017;216:732–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Bardaji A, Sigauque B, Sanz S, et al. Impact of malaria at the end of pregnancy on infant mortality and morbidity. J Infect Dis. 2011;203:691–9.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Mathison BA, Pritt BS. Update on malaria diagnostics and test utilization. J Clin Microbiol. 2017;55:2009–17.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Centers for Disease Control and Prevention. DPDx—laboratory identification of parasitic diseases of public health concern. http://www.cdc.gov/dpdx/contact.html. Accessed 9 Jan 2018.
  30. 30.
    Fried M, Muehlenbachs A, Duffy PE. Diagnosing malaria in pregnancy: an update. Expert Rev Anti-Infect Ther. 2012;10:1177–87.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Boyce MR, O’Meara WP. Use of malaria RDTs in various health contexts across sub-Saharan Africa: a systematic review. BMC Public Health. 2017;17:470.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Zheng Z, Cheng Z. Advances in molecular diagnosis of malaria. Adv Clin Chem. 2017;80:155–92.CrossRefPubMedGoogle Scholar
  33. 33.
    Centers for Disease Control and Prevention. Malaria: Malaria treatment (United States). https://www.cdc.gov/malaria/diagnosis_treatment/treatment.html. Accessed 9 Jan 2018.
  34. 34.
    World Health Organization. Malaria: intermittent preventive treatment in pregnancy (IPTp). Available at http://www.who.int/malaria/areas/preventive_therapies/pregnancy/en/. Accessed 9 Jan 2018.
  35. 35.
    Desai M, Gutman J, L’lanziva A, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomized controlled superiority trial. Lancet. 2015;386:2507–19.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Kakuru A, Jagannathan P, Muhindo MK, et al. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med. 2016;374:928–39.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Divisions of Neonatal/Perinatal Medicine and Pediatric Infectious Diseases, Department of PediatricsUniversity of Texas Health Science Center San AntonioSan AntonioUSA

Personalised recommendations